Naturex posts strong second quarter revenue

Ingredients manufacturer Naturex posted a 32.3 percent revenue growth in the second quarter, with revenues for the first half of the year totaling US$31.4 million.

The company said the acquisitions of Hammer Pharma in January and HP Botanicals in April had contributed to its rapid development.

The French-based manufacturer said plans are underway for an acquisition of a US business that is expected to generate approximately US$10 million in revenues. It also said new projects are currently being studied both in Europe and North America.